IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay

References

• Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19:v1–v88.
   PubMed Web of Science ®Google Scholar
• Black KL, Ningaraj NS. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control. 2004;11:165–173.
   PubMedGoogle Scholar
• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15:829–845.
   PubMed Web of Science ®Google Scholar
• Glorian V, Maillot G, Polès S, et al. HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ. 2011;18(11):1692–1701.
   PubMed Web of Science ®Google Scholar
• Mu Q, Wang L, Yu F, et al. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway. Cancer Biol Ther. 2015;16:623–633.
   PubMed Web of Science ®Google Scholar
• Degrauwe N, Schlumpf TB, Janiszewska M, et al. The RNA binding protein IMP2 preserves glioblastoma stem cells by preventing let-7 target gene silencing. Cell Rep. 2016;15:1634–1647.
   PubMed Web of Science ®Google Scholar
• Mineo M, Ricklefs F, Rooj AK, et al. The long non-coding RNA HIF1A-AS2 facilitates the maintenance of mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell Rep. 2016;15:2500–2509.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1:391–407.
   PubMed Web of Science ®Google Scholar
• Wang L, Yu Z, Sun S, et al. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis. Rev Neurosci. 2017;28:375–380.
   PubMed Web of Science ®Google Scholar
• Worku T, Bhattarai D, Ayers D, et al. Long non-coding RNAs: the new horizon of gene regulation in ovarian cancer. Cell Physiol Biochem. 2017;44:948–966.
   PubMedGoogle Scholar
• Ricciuti B, Mencaroni C, Paglialunga L, et al. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy. Med Oncol. 2016;33(2):18.
   PubMed Web of Science ®Google Scholar
• Zhao J, Mialki RK, Wei J, et al. SCF E3 ligase F-box protein complex SCF FBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation. Faseb J. 2013;27(7):2611–2619.
   PubMed Web of Science ®Google Scholar
• Chandran V. The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol. 2013;44:149–156.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wei J, Mialki RK, et al. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat Immunol. 2012;13:651–658.
   PubMed Web of Science ®Google Scholar
• Shen B, Yuan Y, Zhang Y, et al. Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203. Biochem Biophys Res Commun. 2017;488(1):67–73.
   PubMed Web of Science ®Google Scholar
• Moon B-S, Bai J, Cai M, et al. Kruppel-like factor 4-dependent Staufen1-mediated mRNA decay regulates cortical neurogenesis. Nat Commun. 2018;9(1):401.
   PubMedGoogle Scholar
• Gong C, Kim YK, Woeller CF, et al. SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev. 2009;23:54–66.
   PubMed Web of Science ®Google Scholar
• Cho H, Kim K, Han S, et al. Staufen1-mediated mRNA decay functions in adipogenesis. Mol Cell. 2012;46(4):495–506.
   PubMed Web of Science ®Google Scholar
• Park E, Maquat LE. Staufen-mediated mRNA decay. Wiley Interdiscip Rev RNA. 2013;4:423–435.
   PubMed Web of Science ®Google Scholar
• Park E, Gleghorn ML, Maquat LE. Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity. Proc Natl Acad Sci U S A. 2013;110:405–412.
   PubMed Web of Science ®Google Scholar
• Cassandri M, Smirnov A, Novelli F, et al. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3(1):17071.
   PubMedGoogle Scholar
• Ragusa M, Majorana A, Banelli B, et al. MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis. J Mol Med (Berl). 2010;88(10):1041–1053.
   PubMed Web of Science ®Google Scholar
• Durinck S, Stawiski EW, Pavía-Jiménez A, et al. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015;47:13–21.
   PubMed Web of Science ®Google Scholar
• Arvanitis CD, Askoxylakis V, Guo Y, et al. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A. 2018;115:E8717–E8726.
   PubMed Web of Science ®Google Scholar
• Muller-McNicoll M, Rossbach O, Hui J, et al. Auto-regulatory feedback by RNA-binding proteins. J Mol Cell Biol. 2019;11(10):930–939.
   Web of Science ®Google Scholar
• Lin C, Miles WO, Beyond CLIP. advances and opportunities to measure RBP-RNA and RNA-RNA interactions. Nucleic Acids Res. 2019;47:5490–5501.
   PubMed Web of Science ®Google Scholar
• Png KJ, Halberg N, Yoshida M, et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2011;481:190–194.
   PubMed Web of Science ®Google Scholar
• You D, You H. Repression of long non-coding RNA MEG3 restores nerve growth and alleviates neurological impairment after cerebral ischemia-reperfusion injury in a rat model. Biomed Pharmacother. 2019;111:1447–1457.
   PubMed Web of Science ®Google Scholar
• Ruan W, Li J, Xu Y, et al. MALAT1 up-regulator polydatin protects brain microvascular integrity and ameliorates stroke through C/EBPbeta/MALAT1/CREB/PGC-1alpha/PPARgamma pathway. Cell Mol Neurobiol. 2019;39:265–286.
   PubMed Web of Science ®Google Scholar
• Sa L, Li Y, Zhao L, et al. The Role of HOTAIR/miR-148b-3p/USF1 on regulating the permeability of BTB. Front Mol Neurosci. 2017;10:194.
   PubMed Web of Science ®Google Scholar
• Yu DJ, Li YH, Zhong M. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019;23:4800–4806.
   PubMed Web of Science ®Google Scholar
• Ding Z, Ye P, Yang X, et al. LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718. Biosci Rep. 2019;39. DOI:10.1042/BSR20182018.
   Web of Science ®Google Scholar
• Pan R, He Z, Ruan W, et al. lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346. Onco Targets Ther. 2018;11:8409–8420.
   PubMed Web of Science ®Google Scholar
• Dassi E. Handshakes and fights: the regulatory interplay of RNA-binding proteins. Front Mol Biosci. 2017;4:67.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao X, Zhou W, et al. LIN28A-stabilized FBXL19-AS1 promotes breast cancer migration, invasion and EMT by regulating WDR66. In Vitro Cell Dev Biol Anim. 2019;55:426–435.
   PubMed Web of Science ®Google Scholar
• Hammerle M, Gutschner T, Uckelmann H, et al. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology. 2013;58:1703–1712.
   PubMed Web of Science ®Google Scholar
• Kim YK, Furic L, Desgroseillers L, et al. Mammalian Staufen1 recruits Upf1 to specific mRNA 3ʹUTRs so as to elicit mRNA decay. Cell. 2005;120:195–208.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang KS, Hu B, et al. Systematic analysis of RNA regulatory network in rat brain after ischemic stroke. Biomed Res Int. 2018;2018:8354350.
   PubMed Web of Science ®Google Scholar
• Kim JY, Deglincerti A, Jaffrey SR. A Staufen1-mediated decay pathway influences the local transcriptome in axons. Translation (Austin). 2017;5:e1414016.
   PubMedGoogle Scholar
• Aruga J. Zic Family Proteins in Emerging Biomedical Studies. Adv Exp Med Biol. 2018;1046:233–248.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang P, Liu Y, et al. miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5. J Cell Physiol. 2015;230(3):716–731.
   PubMed Web of Science ®Google Scholar
• Jin Z, Liang J, Li J, et al. Absence of MCP-induced protein 1 enhances blood-brain barrier breakdown after experimental stroke in mice. Int J Mol Sci. 2019;20(13):3214.
   Web of Science ®Google Scholar
• Leduc-Galindo D, Qvist P, Tóth AE, et al. The effect of hypoxia on ZEB1 expression in a mimetic system of the blood-brain barrier. Microvasc Res. 2019;122:131–135.
   PubMed Web of Science ®Google Scholar
• Ma J, Yao Y, Wang P, et al. MiR-181a regulates blood-tumor barrier permeability by targeting Kruppel-like factor 6. J Cereb Blood Flow Metab. 2014;34:1826–1836.
   PubMed Web of Science ®Google Scholar
• Lockman PR, Mittapalli RK, Taskar KS, et al. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res. 2010;16(23):5664–5678.
   PubMed Web of Science ®Google Scholar
• Cote J, Bovenzi V, Savard M, et al. Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model. PLoS One. 2012;7(5):e37485.
   PubMed Web of Science ®Google Scholar
• Ningaraj NS, Rao MK, Black KL. Adenosine 5ʹ-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model. Cancer Res. 2003;63:8899–8911.
   PubMed Web of Science ®Google Scholar
• Cai H, Liu W, Xue Y, et al. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, occludin, and claudin-5 expression. J Neuropathol Exp Neurol. 2015;74:25–37.
   PubMed Web of Science ®Google Scholar
• Sobell HM. Actinomycin and DNA transcription. Proc Natl Acad Sci U S A. 1985;82:5328–5331.
   PubMed Web of Science ®Google Scholar